手动与自动超敏检测法对抑制性抗逆转录病毒治疗患者血浆中残留HIV-1的比较
该研究采用两阶段盲法比较了三种手动和两种自动单拷贝HIV RNA检测法及两种超敏HIV p24检测法在低浓度HIV血浆样本中的性能。第一阶段发现超敏p24检测临床样本的检出率平均为11%,而单拷贝RNA检测平均为61%。第二阶段对80例病毒抑制者的临床血浆样本评估显示,自动单拷贝RNA检测在三个实验室间表现相当,平均检出57%的样本,而手动检测≤40%。
要点
- 超敏p24检测对病毒抑制者临床样本的HIV检出率低(平均11%),单拷贝RNA检测更高(平均61%)。
- 自动单拷贝RNA检测在三个实验室间性能相当,平均检出57%的病毒抑制者样本。
- 手动单拷贝RNA检测对相同样本的检出率≤40%,低于自动检测。
核心结论
- 自动单拷贝RNA检测提供了一种可扩展的测量残留HIV病毒血症的方法,可能广泛用于发病机制和治愈导向研究。
研究设计与样本
- 两阶段盲法比较研究:第一阶段使用系列稀释的分析标准品和病毒学抑制的HIV感染者临床血浆样本进行资格评估。
- 第二阶段使用80例病毒学抑制的HIV感染者临床血浆样本和低拷贝分析标准品评估表现最佳的自动和手动单拷贝RNA检测。
主要发现
- 第一阶段中超敏p24检测临床样本的HIV检出率平均为11%,单拷贝RNA检测平均为61%。
- 第二阶段中自动检测在三个独立实验室表现相当,对病毒抑制者样本的HIV RNA检出率平均为57%。
- 手动检测对相同样本的HIV检出率≤40%。
临床怎么用
- 自动单拷贝RNA检测可用于测量病毒学抑制的HIV感染者的残留病毒血症,适用于治愈研究和分析性治疗中断的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Several nucleic acid and antigen assays have been developed to detect HIV in plasma at levels below the detection limit of standard clinical assays; however, comparative assessment of performance of these ultrasensitive assays on identical panels has been limited. Here, we report the relative performance characteristics of three manual (ultracentrifugation concentration and laboratory-developed PCR) and two automated commercial assays for single-copy detection of HIV RNA, as well as two ultrasensitive HIV p24 assays, using blinded panels of plasma samples containing HIV at low concentrations. Independent sample sets were studied in two phases: in the first phase, qualification panels consisted of analytic standards in serial dilution and clinical plasma samples from virologically suppressed people with HIV (PWH). HIV detection in clinical samples was infrequent using the ultrasensitive p24 assays (mean 11%). In contrast, a higher proportion of the same samples were detected using single-copy RNA assays (mean 61%). In the second phase, evaluation panels of clinical plasma samples (n = 80) from virally suppressed PWH and low-copy analytic standards assessed performance of one automated and two manual single-copy RNA assays with the highest qualification phase detection frequencies. The automated assay performed comparably in three separate laboratories and consistently detected HIV RNA in over half (mean 57%) of samples from virally suppressed PWH, whereas the manual assays detected HIV in ≤40% of the same samples. An automated single-copy assay provides a scalable method for measuring residual HIV viremia that may be broadly useful in pathogenesis and cure-directed studies. IMPORTANCE: Most people with HIV (PWH) on antiretroviral therapy have viral loads below the detection limit of clinical assays, yet virus is often present and detectable at very low levels using ultrasensitive research assays. Clinical trials evaluating curative interventions and interpreting outcomes of analytical treatment interruptions depend on reliable assays to assess and quantify changes in HIV persistence often at very low levels. We conducted a two-stage head-to-head, blinded comparison of multiple ultrasensitive HIV RNA and p24 assays, first using 50 low viral load plasma samples, then further evaluating the top-performing assays on a 144-member blinded panel composed of duplicate contrived and clinical specimens from well-suppressed PWH. Single-copy RNA methods performed better than p24 assays, and a fully automated, 9-replicate commercial RNA assay demonstrated high sensitivity, reproducibility across laboratories, and practical scalability that can be applied to measure the impact of interventions in HIV cure trials.
引用
- Coco SB, Stone M, Deng X, et al. Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapy. J Clin Microbiol. 2025. PMID: 41251360. doi:10.1128/jcm.00995-25
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。